CNS involvement in AML at diagnosis is rare and does not affect response or survival: data from 11 ECOG-ACRIN trials

Central nervous system (CNS) involvement in patients with newly diagnosed acute myeloid leukemia (AML) is rare, and systematic data regarding outcome are scarce. This retrospective study summarized data from 11 consecutive Eastern Cooperative Oncology Group-American College of Radiology Imaging Netw...

Descripción completa

Detalles Bibliográficos
Autores principales: Ganzel, Chezi, Lee, Ju-Whei, Fernandez, Hugo F., Paietta, Elisabeth M., Luger, Selina M., Lazarus, Hillard M., Cripe, Larry D., Douer, Dan, Wiernik, Peter H., Rowe, Jacob M., Tallman, Martin S., Litzow, Mark R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2021
Materias:
Clinical Trials and Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759130/
https://www.ncbi.nlm.nih.gov/pubmed/34597373
http://dx.doi.org/10.1182/bloodadvances.2021004999

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759130/
https://www.ncbi.nlm.nih.gov/pubmed/34597373
http://dx.doi.org/10.1182/bloodadvances.2021004999

Ejemplares similares